NFATc1 in Inflammatory and Musculoskeletal Conditions

被引:16
作者
Aliprantis, Antonios O. [1 ,2 ]
Glimcher, Laurie H. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
来源
OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS II | 2010年 / 658卷
关键词
NFATc1; Osteoclast; Hair follicle; OSTEOCLAST-ASSOCIATED RECEPTOR; T-CELLS C1; NUCLEAR-FACTOR; GENE-EXPRESSION; BONE-RESORPTION; GIANT-CELL; ACTIVATION; RANKL; DIFFERENTIATION; IMMUNE;
D O I
10.1007/978-1-4419-1050-9_8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The nuclear factor of activated T-cells (NFAT) family of transcription factors specify developmental pathways and cell fate in vertebrates. NFATc1, in particular, is crucial to multiple seemingly unrelated biologic processes, including heart valve formation, T-cell activation, osteoclast development, and the mitigation of hair follicle stem cell proliferation. Here, we review how our recently generated NFATc1 conditional knockout mouse has contributed to our understanding of this transcription factor in inflammatory and musculoskeletal conditions and their treatment.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 52 条
[1]
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism [J].
Aliprantis, Antonios O. ;
Ueki, Yasuyoshi ;
Sulyanto, Rosalyn ;
Park, Arnold ;
Sigrist, Kirsten S. ;
Sharma, Sudarshana M. ;
Ostrowski, Michael C. ;
Olsen, Bjorn R. ;
Glimcher, Laurie H. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (11) :3775-3789
[2]
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21 [J].
Arron, Joseph R. ;
Winslow, Monte M. ;
Polleri, Alberto ;
Chang, Ching-Pin ;
Wu, Hai ;
Gao, Xin ;
Neilson, Joel R. ;
Chen, Lei ;
Heit, Jeremy J. ;
Kim, Seung K. ;
Yamasaki, Nobuyuki ;
Miyakawa, Tsuyoshi ;
Francke, Uta ;
Graef, Isabella A. ;
Crabtree, Gerald R. .
NATURE, 2006, 441 (7093) :595-600
[3]
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis [J].
Asagiri, M ;
Sato, K ;
Usami, T ;
Ochi, S ;
Nishina, H ;
Yoshida, H ;
Morita, I ;
Wagner, EF ;
Mak, TW ;
Serfling, E ;
Takayanagi, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (09) :1261-1269
[4]
The molecular understanding of osteoclast differentiation [J].
Asagiri, Masataka ;
Takayanagi, Hiroshi .
BONE, 2007, 40 (02) :251-264
[5]
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone [J].
Atkins, GJ ;
Bouralexis, S ;
Haynes, DR ;
Graves, SE ;
Geary, SM ;
Evdokiou, A ;
Zannettino, ACW ;
Hay, S ;
Findlay, DM .
BONE, 2001, 28 (04) :370-377
[6]
Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[7]
Immune responses and bone loss: the estrogen connection [J].
Carlsten, H .
IMMUNOLOGICAL REVIEWS, 2005, 208 :194-206
[8]
A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis [J].
Chang, CP ;
Neilson, JR ;
Bayle, JH ;
Gestwicki, JE ;
Kuo, A ;
Stankunas, K ;
Graef, IA ;
Crabtree, GR .
CELL, 2004, 118 (05) :649-663
[9]
NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiation [J].
Crotti, Tania N. ;
Flannery, Merrilee ;
Walsh, Nicole C. ;
Fleming, Joseph D. ;
Goldring, Steven R. ;
McHugh, Kevin P. .
GENE, 2006, 372 :92-102
[10]
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J].
Fuller, K ;
Wong, B ;
Fox, S ;
Choi, YW ;
Chambers, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :997-1001